DNA Methylation Signatures Predicting Bevacizumab Efficacy in Metastatic Breast Cancer

Background: Biomarkers predicting response to bevacizumab in breast cancer are still missing. Since epigenetic modifications can contribute to an aberrant regulation of angiogenesis and treatment resistance, we investigated the influence of DNA methylation patterns on bevacizumab efficacy. Methods:...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Theranostics
Main Authors: Gampenrieder, Simon Peter, Rinnerthaler, Gabriel, Hackl, Hubert, Pulverer, Walter, Weinhaeusel, Andreas, Ilic, Suzana, Hufnagl, Clemens, Hauser-Kronberger, Cornelia, Egle, Alexander, Risch, Angela, Greil, Richard
Formato: Artigo
Idioma:Inglês
Publicado em: Ivyspring International Publisher 2018
Assuntos:
Research Paper
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC5928889/
https://ncbi.nlm.nih.gov/pubmed/29721079
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.23544
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados